|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.378
|
|
|
|
microtubule organizing center organization
|
GO:0031023 |
28 |
0.118
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.092
|
|
|
|
translation
|
GO:0006412 |
93 |
0.084
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.077
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.061
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.060
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.056
|
|
|
|
axial mesoderm development
|
GO:0048318 |
8 |
0.051
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.048
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.046
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.043
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.041
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.038
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.036
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.035
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.035
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.035
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.034
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.033
|
|
|
|
ribosome biogenesis
|
GO:0042254 |
20 |
0.033
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
31 |
0.031
|
|
|
|
double strand break repair
|
GO:0006302 |
48 |
0.031
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.030
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.029
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.028
|
|
|
|
skeletal myofibril assembly
|
GO:0014866 |
4 |
0.028
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.028
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.027
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.027
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.027
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.026
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.025
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.025
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.025
|
|
|
|
microglial cell activation
|
GO:0001774 |
3 |
0.024
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.024
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.023
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.023
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.022
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.022
|
|
|
|
centrosome cycle
|
GO:0007098 |
23 |
0.021
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.021
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.021
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.021
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.021
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.020
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.020
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.020
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.019
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.019
|
|
|
|
intra s dna damage checkpoint
|
GO:0031573 |
4 |
0.019
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.019
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.019
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.018
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.018
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.018
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.017
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.017
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.017
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.016
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.016
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.016
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.016
|
|
|
|
brain segmentation
|
GO:0035284 |
3 |
0.016
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.016
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.015
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.015
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.015
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.015
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.015
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.014
|
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.014
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.014
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.013
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.013
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.013
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.013
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.013
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.013
|
|
|
|
positive regulation of transcription from rna polymerase i promoter
|
GO:0045943 |
3 |
0.013
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.013
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.013
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.013
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.013
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.013
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.013
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.012
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.012
|
|
|
|
mitotic g2 dna damage checkpoint
|
GO:0007095 |
8 |
0.012
|
|
|
|
response to thyroid hormone
|
GO:0097066 |
2 |
0.012
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.012
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.012
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.012
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.011
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.011
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.011
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.011
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.011
|
|
|
|
regulation of translational elongation
|
GO:0006448 |
4 |
0.011
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.011
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.011
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.011
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.011
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.010
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.010
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.010
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.010
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.010
|
|
|
|
ribosomal small subunit biogenesis
|
GO:0042274 |
4 |
0.010
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.010
|
|